Residual daytime sleepiness in patients with obstructive sleep apnoea syndrome: A service review in a tertiary sleep centre
Sleep and Breathing · 2026-05 · 30 (2)
DOI: 10.1007/s11325-026-03655-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sleep and Breathing, online erschienen am 28.03.2026. Verfasst von Jasvinder Singh Kaler und 3 weiteren Autor:innen. Beteiligte Einrichtung: Sleep Disorders Centre, Guy's & St Thomas' NHS Foundation Trust, London, UK. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Disorders of Excessive Somnolence, Continuous Positive Airway Pressure. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bioprojet UK.
Abstract (Originalsprache)
Rationale
Obstructive Sleep Apnoea Hypopnoea Syndrome (OSAHS) is frequently associated with excessive daytime sleepiness (EDS). There are sparse data on patients with OSAHS who are well treated with continuous positive airway pressures (CPAP) but continue to experience residual EDS. We sought to prospectively review a patient cohort to understand causes associated with this symptom.
Methods
Patients with OSA and documented evidence of CPAP usage and respiratory control were recruited from a large tertiary referral centre (GSTT/2024/16137). Data are presented as mean (standard deviation).
Results
Data were collected between 05/2024 and 01/2025. Out of 63 patients that were identified and pre-screened, we included 50 (age 56.7 (13.1) years, gender (male: female) 33:17, body mass index, BMI 36.6 (9.5) kg/m 2 ). Patients had been diagnosed with OSAHS (AHI 36.7 (20.0) events x hour − 1 ; residual AHI on CPAP 4.2 (3.8) events x hour − 1 ; p < 0.0001), were adherent to CPAP (6.2 (1.6) hours x night − 1 ), and remained sleepy (pre-therapeutic ESS 17.6 (3.7) points; residual ESS on therapy 14.9 (4.0) points; p < 0.0001). Common comorbidities included chronic pain (46%), Restless Legs Syndrome/Periodic Limb Movement Disorder (34%), mental health issues (anxiety/depression, 68%), other sleep disorders (36%), cardiovascular disease (68%), and type-2 diabetes (32%). Co-medication included analgesia (22%), antidepressants (58%), dopaminergic drugs (10%); antihypertensives (56%), antidiabetics (22%), no patient was taking benzodiazepines.
Conclusion
The identified cohort of patients with OSA and residual EDS still experienced a significant improvement of their symptoms with CPAP therapy. However, residual EDS may be attributable to substantial comorbidities with sleep fragmentation and co-medication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sleep Disorders Centre, Guy's & St Thomas' NHS Foundation Trust, London, UK.
- Liverpool Sleep and Ventilation Centre, University Hospital Aintree, University Hospitals of Liverpool Group, Liverpool, UK.
- Sleep Disorders Centre, Guy's & St Thomas' NHS Foundation Trust, London, UK. Joerg.steier@nhs.net.
- Faculty of Life Sciences & Medicine, King's College London, Centre for Human and Applied Physiological Sciences, London, UK. Joerg.steier@nhs.net.
Förderung
- Bioprojet UK
Zitieren
APA
Kaler, J. S., Chakrabarti, B., Craig, S., & Steier, J. (2026). Residual daytime sleepiness in patients with obstructive sleep apnoea syndrome: A service review in a tertiary sleep centre. Sleep and Breathing, 30(2). https://doi.org/10.1007/s11325-026-03655-6
Vancouver
Kaler JS, Chakrabarti B, Craig S, Steier J. Residual daytime sleepiness in patients with obstructive sleep apnoea syndrome: A service review in a tertiary sleep centre. Sleep and Breathing. 2026;30(2). doi:10.1007/s11325-026-03655-6
BibTeX
@article{Kaler2026,
author = {Kaler, Jasvinder Singh and Chakrabarti, Biswajit and Craig, Sonya and Steier, Joerg},
title = {Residual daytime sleepiness in patients with obstructive sleep apnoea syndrome: A service review in a tertiary sleep centre},
journal = {Sleep and Breathing},
year = {2026},
volume = {30},
number = {2},
doi = {10.1007/s11325-026-03655-6}
}
EUVIMED